Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Cancer Patients
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: OTHER: Pre-Test Intervention|OTHER: Standard of Care|OTHER: Post-Test Intervention
Sponsor: Abramson Cancer Center at Penn Medicine
Collaborators: AstraZeneca|Fox Chase Cancer Center|Basser Center for BRCA|Merck Sharp & Dohme LLC